DE450812T1 - Antihypercholesterolemika. - Google Patents

Antihypercholesterolemika.

Info

Publication number
DE450812T1
DE450812T1 DE199191302458T DE91302458T DE450812T1 DE 450812 T1 DE450812 T1 DE 450812T1 DE 199191302458 T DE199191302458 T DE 199191302458T DE 91302458 T DE91302458 T DE 91302458T DE 450812 T1 DE450812 T1 DE 450812T1
Authority
DE
Germany
Prior art keywords
image
hypercholesterolemic
compounds
useful
structural formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE199191302458T
Other languages
English (en)
Inventor
James D. Neshanic Nj 08853 Us Bergstrom
Jerrold M. Princeton Junction Nj 08550 Us Liesch
Otto D. Red Bank Nj 07701 Us Hensens
Janet C. Mountainside Nj 07092 Us Onishi
Leeyuan Watchung Nj 07060 Us Huang
Frank L. Fanwood Nj 07023 Us Vanmiddlesworth
Maria T. E-28010 Madrid Es Diez
Kenneth F. Somerset Nj 08873 Us Bartizal
Mary Westfield Nj 07090 Us Nallin
Walter Cliffwood Beach Nj 07735 Us Rozdilsky
Fernando Pelaez N-110 4- C-28038 Madrid Es Perez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/496,742 external-priority patent/US5096923A/en
Priority claimed from US07/626,071 external-priority patent/US5053425A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE450812T1 publication Critical patent/DE450812T1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
DE199191302458T 1990-03-21 1991-03-21 Antihypercholesterolemika. Pending DE450812T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49673190A 1990-03-21 1990-03-21
US49674990A 1990-03-21 1990-03-21
US07/496,742 US5096923A (en) 1990-03-21 1990-03-21 Novel squalene synthetase inhibitors
US07/626,071 US5053425A (en) 1990-03-21 1990-12-11 Novel anti-fungal compounds

Publications (1)

Publication Number Publication Date
DE450812T1 true DE450812T1 (de) 1992-11-26

Family

ID=27504381

Family Applications (2)

Application Number Title Priority Date Filing Date
DE199191302458T Pending DE450812T1 (de) 1990-03-21 1991-03-21 Antihypercholesterolemika.
DE69101802T Expired - Fee Related DE69101802T2 (de) 1990-03-21 1991-03-21 Antihypercholesterolemika.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69101802T Expired - Fee Related DE69101802T2 (de) 1990-03-21 1991-03-21 Antihypercholesterolemika.

Country Status (17)

Country Link
EP (1) EP0450812B1 (de)
JP (1) JPH04279589A (de)
KR (1) KR910016931A (de)
AT (1) ATE104982T1 (de)
AU (1) AU640755B2 (de)
CA (1) CA2038517A1 (de)
CS (1) CS71991A2 (de)
DE (2) DE450812T1 (de)
DK (1) DK0450812T3 (de)
ES (1) ES2052463T1 (de)
GR (1) GR920300106T1 (de)
HU (1) HUT61555A (de)
IE (1) IE910924A1 (de)
IL (1) IL97535A0 (de)
NO (1) NO911121L (de)
NZ (1) NZ237448A (de)
PT (1) PT97077A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97251A0 (en) * 1990-03-21 1992-05-25 Merck & Co Inc Antihypercholesterolemic 2,8-dioxabicyclo(3,2,1)octane derivatives,their preparation and pharmaceutical compositions containing them
GB9100437D0 (en) * 1991-01-09 1991-02-20 Glaxo Group Ltd Chemical compounds
GB9105152D0 (en) * 1991-03-12 1991-04-24 Glaxo Group Ltd Chemical compounds
US5256689A (en) * 1991-05-10 1993-10-26 Merck & Co., Inc. Cholesterol lowering compounds
CA2109523A1 (en) * 1991-05-10 1992-11-26 Robert M. Burk Novel cholesterol lowering compounds
US5506262A (en) * 1991-05-10 1996-04-09 Merck & Co., Inc. Cholesterol lowering compounds
US5200342A (en) * 1991-06-14 1993-04-06 Merck & Co., Inc. Squalene synthetase inhibitors and processes therefrom
US5250424A (en) * 1991-06-14 1993-10-05 Merck & Co., Inc. Processes for preparing novel squalene synthetase inhibitors
CA2071723A1 (en) * 1991-06-27 1992-12-28 Gerald F. Bills Culture of exserohilum rostratum and processes therefrom
EP0524677A1 (de) * 1991-07-16 1993-01-27 Glaxo Group Limited Zyklische Ketalderivate
EP0598021A1 (de) * 1991-08-07 1994-05-25 Merck & Co. Inc. Cholesterolsenkende Verbindung
GB9121380D0 (en) * 1991-10-08 1991-11-20 Glaxo Group Ltd Chemical compounds
GB2261374A (en) * 1991-11-15 1993-05-19 Merck & Co Inc Inhibitors of farnesyl protein transferase as anti-cancer agents
US5252471A (en) * 1992-03-09 1993-10-12 Merck & Co., Inc. Directed biosynthesis of cholesterol lowering compounds
WO1993017557A1 (en) * 1992-03-09 1993-09-16 Merck & Co., Inc. Cholesterol lowering compounds produced by directed biosynthesis
US5294627A (en) * 1992-08-27 1994-03-15 Merck & Co., Inc. Directed biosynthesis of biologically active compounds
GB9205136D0 (en) * 1992-03-10 1992-04-22 Glaxo Group Ltd Chemical compounds
GB9205140D0 (en) * 1992-03-10 1992-04-22 Glaxo Group Ltd Chemical compounds
EP0568946A1 (de) * 1992-05-08 1993-11-10 Takeda Chemical Industries, Ltd. Verbindung TAN-1607A, ihre Derivate, deren Herstellung und Verwendung
US5260215A (en) * 1992-07-20 1993-11-09 Merck & Co., Inc. Fungal microorganism ATCC 74167 capable of producing cholesterol lowering compounds
US5283256A (en) * 1992-07-22 1994-02-01 Merck & Co., Inc. Cholesterol-lowering agents
US5322855A (en) * 1992-10-19 1994-06-21 Merck & Co., Inc. Cholesterol lowering compounds
US5447717A (en) * 1993-02-25 1995-09-05 Merck & Co., Inc. Cholesterol-lowering agents
US5430055A (en) * 1994-04-08 1995-07-04 Pfizer Inc. Inhibitor of squalene synthase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276216A (en) * 1980-07-31 1981-06-30 Ortho Pharmaceutical Corporation Synthesis of dioxabicyclo[3.2.1]octanes and oxepanes
IL97251A0 (en) * 1990-03-21 1992-05-25 Merck & Co Inc Antihypercholesterolemic 2,8-dioxabicyclo(3,2,1)octane derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69101802T2 (de) 1994-10-27
HUT61555A (en) 1993-01-28
NO911121L (no) 1991-09-23
DE69101802D1 (de) 1994-06-01
IE910924A1 (en) 1991-09-25
AU7368391A (en) 1993-01-28
NZ237448A (en) 1993-11-25
HU910930D0 (en) 1991-10-28
PT97077A (pt) 1991-11-29
NO911121D0 (no) 1991-03-20
AU640755B2 (en) 1993-09-02
KR910016931A (ko) 1991-11-05
CS71991A2 (en) 1991-11-12
EP0450812A1 (de) 1991-10-09
IL97535A0 (en) 1992-06-21
ATE104982T1 (de) 1994-05-15
GR920300106T1 (en) 1993-02-17
CA2038517A1 (en) 1991-09-22
ES2052463T1 (es) 1994-07-16
DK0450812T3 (da) 1994-06-06
JPH04279589A (ja) 1992-10-05
EP0450812B1 (de) 1994-04-27

Similar Documents

Publication Publication Date Title
DE450812T1 (de) Antihypercholesterolemika.
ES2080297T3 (es) Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.
YU25497A (sh) Postupak za dobijanje sildenafila
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE69429173T2 (de) Taxolderivate
GR3023457T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
PT100357A (pt) Compostos lactama macrociclicos, seu processo de preparacao e intermediarios, e composicoes que os contem
ATE153657T1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
DE69431824T2 (de) Verfahren zur Herstellung von Schwefelhaltigen Imidazolderivaten und erhaltene Zwischenprodukte
ES2077867T3 (es) 3-carbamoil-4-hidroxicumarinas antihelminticas y anticoccidiales, procedimiento de uso y composiciones.
DE69413112D1 (de) 5-HT3 Pyrrolopyrazinderivate
ES2103816T3 (es) Carbamatos de indano pirrolidina.
SE8001620L (sv) Merkaptoacylderivat av ketosubstituerad prolin- och pipekolinsyra
DE69303333D1 (de) Substituierte Benzoate-Derivate
DE69025817T2 (de) 3-Keto-HMG-CoA Reduktase-Inhibitoren
IT1255094B (it) Derivati tetraidropiridoimidazolonici come agenti nootropici